Celularity shares are trading higher after the company released a CEO letter to shareholders. For full year 2023 the company said it expects net sales percentage growth in the range of 22.7% to 26.6% year over year.
Portfolio Pulse from Benzinga Newsdesk
Celularity Inc. shares have risen following a CEO letter to shareholders projecting net sales growth of 22.7% to 26.6% for the full year 2023.

January 18, 2024 | 7:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Celularity Inc. is experiencing a rise in share price after the CEO's optimistic sales growth forecast for 2023.
The positive sales growth forecast provided by the CEO is a strong indicator of the company's future performance and is likely to instill confidence in investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100